Stay updated on Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer
Sign up to get notified when there's something new on the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page.

Latest updates to the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page
- Check7 days agoChange DetectedRemoved the 'Ovarian cancer' condition tag and the related topic 'MedlinePlus Genetics' from the page, reducing visible context and linked related information.SummaryDifference0.0%

- Check14 days agoChange DetectedAdded related topic tags for 'Ovarian cancer' and 'MedlinePlus Genetics', and updated the site revision from v3.4.3 to v3.5.0. These changes mainly impact navigation and versioning rather than the study details.SummaryDifference0.1%

- Check22 days agoChange DetectedRemoved related topics entries 'Ovarian cancer' and 'MedlinePlus Genetics' from the Related Topics section.SummaryDifference0.0%

- Check29 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision: v3.4.2 is now shown on the page in place of Revision: v3.4.1.SummaryDifference0.0%

- Check57 days agoChange DetectedMinor release: site revision updated from v3.4.0 to v3.4.1; no visible changes to the study details page.SummaryDifference0.0%

Stay in the know with updates to Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page.